Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quick ratio | 7.1x | 9.9x | 13.2x | 1.2x | 4.6x | 0.9x | 1.6x | 2.3x | 3.4x | 1.2x | 1.7x | 2.6x | 3.8x | 2.8x | 5.8x | 3.5x | 6.2x | 7.0x | 8.9x | 4.1x |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Quick ratio is 4.2x, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Quick ratio for United Therapeutics Corporation have been 7.1x over the past three years, and 7.0x over the past five years.
As of today, United Therapeutics Corporation's Quick ratio is 4.2x, which is higher than industry median of 4.1x. It indicates that United Therapeutics Corporation's Quick ratio is Good.